Covered recipient · General Payments record
ELNARA MURADOVA
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2022–2024
$1,375.50
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $282.28 | 10 |
| Education | $99.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $130.85 | 2 |
| ABBVIE INC. | $75.56 | 3 |
| UCB, Inc. | $61.64 | 2 |
| Amgen Inc. | $52.00 | 2 |
| GENZYME CORPORATION | $40.85 | 1 |
| Arcutis Biotherapeutics, Inc. | $20.38 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.16 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105083121 | CMS |
| ABBVIE INC. | $21.88 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105083123 | CMS |
| ABBVIE INC. | $31.52 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105083125 | CMS |
| Amgen Inc. | $21.47 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117334946 | CMS |
| Amgen Inc. | $30.53 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117334948 | CMS |
| Arcutis Biotherapeutics, Inc. | $20.38 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121045923 | CMS |
| GENZYME CORPORATION | $40.85 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139580372 | CMS |
| Janssen Biotech, Inc. | $99.00 | 05/01/2024 | Education | Undisputed | 01/23/2026 | 1078722496 | CMS |
| Janssen Biotech, Inc. | $31.85 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078722572 | CMS |
| UCB, Inc. | $33.56 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143227141 | CMS |
| UCB, Inc. | $28.08 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143227145 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.